**Core Concept**
Long-acting neuromuscular blockers are a class of drugs that inhibit the transmission of nerve impulses at the neuromuscular junction, resulting in prolonged muscle relaxation. These agents are used in anesthesia to facilitate endotracheal intubation and in the management of patients with status asthmaticus or other conditions requiring muscle relaxation.

**Why the Correct Answer is Right**
The correct answer is a long-acting non-depolarizing neuromuscular blocker that works by competitively blocking the nicotinic acetylcholine receptors at the neuromuscular junction. This competitive inhibition prevents acetylcholine from binding to the receptors, thereby preventing muscle contraction. The agent has a prolonged duration of action, typically lasting 3-5 hours, and is used in clinical settings where prolonged muscle relaxation is required.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it is a short-acting non-depolarizing neuromuscular blocker. Short-acting agents like atracurium have a duration of action of less than 1 hour.
* **Option B:** This option is incorrect as it is a depolarizing neuromuscular blocker. Depolarizing agents like succinylcholine work by activating the nicotinic acetylcholine receptors, causing muscle contraction followed by prolonged relaxation.
* **Option D:** This option is incorrect as it is an anticholinesterase agent. Anticholinesterase agents like neostigmine work by inhibiting the enzyme acetylcholinesterase, thereby increasing the concentration of acetylcholine at the neuromuscular junction and enhancing muscle contraction.

**Clinical Pearl / High-Yield Fact**
When using long-acting neuromuscular blockers, it is essential to monitor the patient's neuromuscular function regularly to prevent prolonged paralysis and respiratory muscle weakness.

**Correct Answer: C. Rocuronium. Rocuronium is a long-acting non-depolarizing neuromuscular blocker.**